Clorox (NYSE:CLX) Releases FY 2026 Earnings Guidance

Clorox (NYSE:CLX) updated its FY 2026 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 5.450-5.650 for the period, compared to the consensus estimate of 5.860. The company issued revenue guidance of $6.7 billion-$6.7 billion, compared to the consensus revenue estimate of $6.7 billion.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on CLX. Rothschild & Co Redburn set a $117.00 price objective on shares of Clorox in a research note on Friday, February 13th. Wells Fargo & Company dropped their target price on shares of Clorox from $110.00 to $100.00 and set an “equal weight” rating for the company in a research report on Friday. Citigroup dropped their target price on shares of Clorox from $110.00 to $97.00 and set a “neutral” rating for the company in a research report on Friday. Wall Street Zen raised shares of Clorox from a “sell” rating to a “hold” rating in a research report on Saturday, February 7th. Finally, Jefferies Financial Group dropped their target price on shares of Clorox from $151.00 to $139.00 and set a “buy” rating for the company in a research report on Tuesday, April 21st. One research analyst has rated the stock with a Buy rating, twelve have assigned a Hold rating and four have given a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Reduce” and an average price target of $104.93.

Clorox Trading Down 9.7%

CLX traded down $9.36 on Friday, reaching $87.08. 13,250,607 shares of the company’s stock were exchanged, compared to its average volume of 2,359,509. The company has a debt-to-equity ratio of 71.03, a quick ratio of 0.48 and a current ratio of 0.74. Clorox has a twelve month low of $86.00 and a twelve month high of $140.24. The company’s 50 day moving average is $108.21 and its 200-day moving average is $108.82. The company has a market cap of $10.53 billion, a price-to-earnings ratio of 14.23, a PEG ratio of 0.48 and a beta of 0.65.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.55 by $0.09. Clorox had a net margin of 11.18% and a return on equity of 379.46%. The company had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.67 billion. During the same quarter last year, the company earned $1.45 earnings per share. Clorox’s revenue for the quarter was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Equities analysts predict that Clorox will post 5.87 earnings per share for the current year.

Clorox Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 8th. Shareholders of record on Wednesday, April 22nd will be given a $1.24 dividend. The ex-dividend date of this dividend is Wednesday, April 22nd. This represents a $4.96 annualized dividend and a yield of 5.7%. Clorox’s dividend payout ratio (DPR) is 81.05%.

Clorox News Summary

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: Q3 results beat on the bottom line as cost cuts and lower spending lifted non‑GAAP EPS to $1.64, above estimates, showing operational leverage despite flat sales. Read More.
• Positive Sentiment: Management is emphasizing innovation and strategic moves to drive future growth — a narrative investors may watch if execution improves. Read More.
• Neutral Sentiment: The company provided Q3 filings, an earnings call transcript and a formal press release; these sources contain details on segment trends and cost actions for modeling. Read More. • Read More.
• Negative Sentiment: Clorox trimmed FY‑2026 guidance (EPS and sales), citing weaker demand and market‑share headwinds — management’s guidance was well below consensus, which is the main catalyst for the selloff. Read More.
• Negative Sentiment: Several large brokers cut price targets and shifted to neutral/underweight after the update (Morgan Stanley, Citi, JPMorgan, Wells Fargo), increasing short‑term selling pressure. Read More. • Read More.
• Negative Sentiment: A shareholder law firm announced an investigation into possible securities‑fraud claims related to Clorox’s statements, adding regulatory/legal risk that can weigh on sentiment. Read More.
• Negative Sentiment: Shares hit new 52‑week lows and traded at much higher volumes, signaling broad repositioning by investors and momentum that could continue until clarity on sales/margin recovery arrives. Read More.

Institutional Trading of Clorox

Several large investors have recently bought and sold shares of the company. Haverford Trust Co grew its position in Clorox by 2.8% in the fourth quarter. Haverford Trust Co now owns 3,070 shares of the company’s stock valued at $310,000 after acquiring an additional 84 shares in the last quarter. Golden State Wealth Management LLC grew its position in Clorox by 28.2% in the fourth quarter. Golden State Wealth Management LLC now owns 454 shares of the company’s stock valued at $46,000 after acquiring an additional 100 shares in the last quarter. Johnson Financial Group Inc. grew its position in Clorox by 3.1% in the third quarter. Johnson Financial Group Inc. now owns 3,659 shares of the company’s stock valued at $451,000 after acquiring an additional 109 shares in the last quarter. State of Wyoming boosted its stake in shares of Clorox by 4.7% during the 2nd quarter. State of Wyoming now owns 2,540 shares of the company’s stock valued at $305,000 after buying an additional 113 shares during the last quarter. Finally, Compound Planning Inc. boosted its stake in shares of Clorox by 6.5% during the 4th quarter. Compound Planning Inc. now owns 2,123 shares of the company’s stock valued at $214,000 after buying an additional 129 shares during the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.